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Abstract  
Background/Objectives 
Previous studies have linked maternal pre-pregnancy obesity (BMI ≥30 kg/m2) with 
suboptimal neurodevelopment in her offspring; however, the literature is not entirely 
consistent. Whether these effects are muddled by maternal self-reports of pre-pregnancy 
weight and height, or are driven or amplified by the well often co-morbid hypertensive and 
diabetic pregnancy and pre-pregnancy disorders, remains unclear. We examined if maternal 
early pregnancy obesity is associated with developmental delay in her offspring, and if the 
associations are driven or amplified by diabetic and hypertensive pregnancy and pre-
pregnancy disorders. 
Subjects/Methods 
2504 mother-child dyads participated in the Prediction and Prevention of Preeclampsia and 
Intrauterine Growth Restriction (PREDO) study. Data on maternal early pregnancy obesity, 
pre-pregnancy and gestational hypertension, pre-eclampsia, type 1 and gestational diabetes 
were derived from the Finnish Medical Birth Register. At the child’s mean age of 42.1 
(SD=8.2) months the mothers completed the Ages and Stages Questionnaire (ASQ) Third 
edition for developmental milestones. 
Results 
Children of obese mothers had 1.81 to 2.74 (p-values<0.02) higher odds of failing to meet the 
development that is typical for a child’s age (developmental domain score ≤ -2SD below the 
child’s age) on the communication, fine and gross motor, problem solving and personal/social 
skills and children of overweight mothers had 2.14 (p=0.002) higher odds of failing to meet 
the development that is typical for the child’s age on communication skills. Odds of 
developmental delay were also higher for children of mothers with pre-eclampsia and 
gestational diabetes. The associations were robust to covariates and confounders, the effects 
of overweight/obesity and pre-eclampsia were not driven by the other disorders, and 
overweight/obesity and hypertensive and diabetic disorders did not show additive effects.   
Conclusions 
Maternal early pregnancy overweight, obesity, and pre-eclampsia are independently 
associated with neurodevelopmental delay in her offspring. Further studies unravelling the 
underlying mechanisms are warranted. 
Keywords  
Pregnancy, obesity, diabetic and hypertensive pregnancy and pre-pregnancy disorders, 
neurodevelopment, children 
Introduction 
Maternal obesity during pregnancy has become one of the major challenges of obstetric 
care(1). Of the world’s adult population of women, including women of the childbearing age, 
14% were obese in 2014(1).  This number is forecasted to increase to 21% by 2025(1). The 
risks of obesity for pregnant mothers include gestational diabetes and hypertension spectrum 
pregnancy disorders, caesarian section delivery and for the offspring preterm birth, 
intrauterine growth restriction, macrosomia and related illnesses and complications, stillbirth 
and congenital anomalies(2).  
Apart from increasing the long-term health risks for the mother, evidence also suggests that 
maternal pre-pregnancy/early pregnancy obesity is associated with long-term 
neurodevelopmental adversities in the offspring(2). These include child’s general 
developmental delay(3), developmental delays in gross motor skills, especially in sitting 
without support and crawling on hands and knees(4), delays in fine motor skills(5), lower 
intelligence quotient(6-10), poorer verbal skills(11), increased risk for symptoms of 
ADHD(11-13), and diagnoses of ASD(3, 11). Yet, some studies have reported null 
associations between maternal obesity and cognitive and motor function(14), and some even 
beneficial effects on cognitive and language development in the offspring(15).  
With one exception that measured maternal weight and height at the first antenatal clinical 
visit(13), the previous studies are limited by relying on maternal self-reported, and not 
objectively verified pre-pregnancy weight and height, in some studies even months after 
delivery(6, 8, 10, 11), or by using a measure that pools self-reported data with data from 
medical records(3-5, 7, 9, 12, 14, 15); of note, in the Upstate KIDS study(5) only 1.6% of 
maternal weight and height measurements were self-reported. Self-reports of weight and 
height are well-known to be biased (16, 17). This may result in misclassification of women 
into groups according to BMI. Hence, it still remains to be verified if neurodevelopmental 
disadvantages in the offspring can be assigned to maternal pre-pregnancy/early pregnancy 
obesity, and if some of the discrepancies in the previous literature arise from inaccuracies in 
anthropometric measurements. 
Furthermore, it remains unknown if neurodevelopmental disadvantages in the offspring are 
specific to maternal pre-pregnancy/early pregnancy obesity, or are driven or amplified by the 
well often co-morbid pregnancy disorders. Existing data suggests that gestational diabetes(18, 
19) and hypertension spectrum pregnancy disorders(20-23) may carry adverse
neurodevelopmental consequences on the offspring that are independent of maternal 
pregnancy BMI or obesity. But whether the same holds true for maternal obesity independent 
of these other disorders, still remains unknown. 
To address these gaps in the literature, we tested the hypothesis that maternal early pregnancy 
obesity, derived from the Finnish Medical Birth Register (MBR)(24), comprising 
measurements verified at the first antenatal clinical visit when pregnancy weight gain is still 
minimal, is associated with delays in developmental milestones in the 23-69-month-old 
offspring. Because some studies suggest that neurodevelopmental adversities not only 
characterize offspring from obese, but from overweight pregnancies as well(7, 11), we also 
tested the hypothesis that maternal overweight is associated with delays in the offspring 
developmental milestones. We further tested if the associations between overweight/obesity 
and child neurodevelopment were independent of the common comorbid disorders, namely 
gestational and pre-pregnancy hypertension, pre-eclampsia, gestational diabetes and type 1 
diabetes. We expected that these disorders, that otherwise complicate pregnancy, may 
partially explain any potential adverse effects of maternal overweight/obesity on offspring 
developmental milestones as the previous discrepant findings may also arise from different 
prevalence of these disorders in the previous studies samples. Finally, we tested if exposure to 
any combination of these disorders amplified adverse neurodevelopmental effects on the 
offspring.   
 
Subjects and Methods 
 
Study design and participants 
The participants came from the Prediction and Prevention of Preeclampsia and Intrauterine 
Growth Restriction (PREDO) Study(25).The PREDO study enrolled 4785 pregnant women, 
of whom 4777 (8 miscarriages or stillbirths) gave birth to a singleton live-born child between 
2006-2010. The women were recruited to the study when they visited antenatal clinics at one 
of the ten study hospitals in Southern and Eastern Finland for their first ultrasound screening 
between 12+0 and 13+6 weeks+days of gestation. To enrich the number of women with pre-
eclampsia and intrauterine growth restriction in the PREDO sample, 969 women were 
recruited based on having one or more risk factors of pre-eclampsia, including pre-pregnancy 
obesity(25). 
 
In 2011-2012, 4586 women and their children were invited for a follow-up (one child had 
died, 33 did not have data in the MBR, 55 women had declined participation in a follow-up, 
for 100 women addresses were not traceable). Of them, 2667(58.2%) participated at a child’s 
mean age of 42.1 months (range 23.2-68.8 months) and 2504(54.6%) provided valid age-
appropriate data on child developmental milestones (163, 6.1%, filled in the developmental 
milestones questionnaire too early or too late for age, we allowed 30% deviation from 
questionnaire-specific age translating into 3 weeks at the youngest age group and 2.7 months 
in the oldest age group).  
In comparison to those who were invited and did not participate (n=1919), mothers of the 
children who participated were older (31.8 vs 31.1 years), more often primiparous (41.2% vs 
35.4%), and had a higher level of education (37.5% vs 46.4% secondary or less, 26.6% vs 
25.0% lower tertiary, 35.9% vs 28.6% upper tertiary) (p-values < 0.001); there were no 
differences in other obstetric/perinatal characteristics. 
Ethics committee approval 
Ethics Committees of the Helsinki and Uusimaa Hospital District and participating hospitals 
approved the study protocol. All participants and parents/guardians provided written informed 
consent.  
Overweight, obesity and related pregnancy and pre-pregnancy disorders 
Data were extracted from the MBR. Each diagnosis was further verified by a clinical jury for 
the subsample recruited based on their increased risk of pre-eclampsia and intrauterine growth 
restriction.  
Early pregnancy BMI was calculated from weight and height verified by a nurse at the first 
visit to the antenatal clinic (M=8+4 weeks+days, SD= 1+3 weeks+days of gestation), and 
categorized to normal weight (24.99 kg/m2 or less), overweight (25-29.99kg/m2), and obese 
(30 kg/m2) groups according to the WHO criteria; 86 women (3.4%) had a BMI below 18.5 
kg/m2 indicating underweight; the underweight and normal weight groups were pooled for the 
analyses (from here on referred to as ‘normal weight’). At the mean 8th gestational week, 
pregnancy weight gain is still minimal. Hence, this measurement is a close proxy of pre-
pregnancy BMI. 
 
Gestational diabetes was defined as fasting, 1h or 2h plasma glucose during a 75g oral 
glucose tolerance test ≥5.1, 10.0 or 8.5 mmol/L that emerged or was first identified during 
pregnancy; Gestational hypertension as blood pressure ≥140/90 mmHg on ≥ 2 occasions at 
least 4 h apart in a woman who was normotensive before 20th week of gestation; Preeclampsia 
as blood pressure ≥140/90 mmHg on ≥2 occasions at least 4 h apart in a women who was 
normotensive before 20th week of gestation with proteinuria ≥300 mg/24 h.  
 
We also identified women with type 1 diabetes (none of the women in our sample had type 2 
diabetes) and with pre-pregnancy/chronic hypertension defined as blood pressure≥140/90 
mmHg present pre-pregnancy or diagnosed before 20th week of gestation. 
 
Developmental milestones  
The Ages and Stages Questionnaires (ASQ) Third edition(26) (translated into Finnish, back-
translated and approved by the publisher) is a tool with excellent test-retest reliability, intra-
observer reliability, internal consistency and concurrent validity, high sensitivity and 
specificity to screen children requiring further developmental assessment, monitoring or 
special education(26-28). It comprises 30 age-appropriate items (in our sample for children 
aged 22.2-26.2, n=83, 24.5-29.5, n=83, 27.5-32.5, n=108, 30.5-35.5, n=241, 33.0-41.5, 
n=450, 37.0-47.0, n=564, 42.0-53.0, n=702, 55.0-59.0, n=239, and 54.0-69.0 months, n= 34)  
measuring communication, gross motor, fine motor, problem solving and personal/social 
skills.  
 Each of the five domains comprise six questions with response ‘yes’ (scored 10) indicating 
the child can master the skill, ‘sometimes’ (scored 5) if the skill is emerging or occasional, 
and ‘not yet’ (scored 0) if the child is not able perform the skill. On each of these domains, 
the scores range from 0 to 60 with the highest value indicating that the child can master the 
skill. According to the ASQ manual and validation studies(26-29), children whose domain 
score is ≤-2 SDs below the mean of the child’s age were considered to fail to meet the 
development that is typical for the child’s age, and hence display developmental delay on that 
specific domain. Scores between -2SDs> and ≤-1SDs below the mean of the child’s age on 
any of the ASQ domains were considered to indicate milder developmental delay(29). This 
milder criteria has also been recommended for screening purposes for agencies that have 
sufficient resources(26). Children with scores >-1SD of the mean of the child’s age were 
considered to display no developmental delay and hence to be developing typically for child’s 
age. We also summed up the number of times the child displayed no developmental delay for 
child’s age (scored 0), mild developmental delay for child’s age (scored 1) and failed to meet 
the development that is typical for child’s age (scored 2) on any of the five ASQ domains 
(range 0-10). This sum-score reflected severity and pervasiveness of the child’s 
developmental delay across the five developmental domains.  
 
Covariates and confounders 
The following factors were included as covariates in our analysis: maternal age at childbirth 
(years), parity (primiparous/multiparous), delivery mode (vaginal/caesarian), maternal 
smoking during pregnancy (did not smoke/quit during first trimester/smoked throughout 
pregnancy), child’s gestational age at delivery (weeks), birth weight (grams), and sex 
(boy/girl) with data extracted from patient case reports and/or the MBR, and maternal alcohol 
use during pregnancy (yes/no/missing) and education level (basic/secondary vs. tertiary) as 
self-reported in a questionnaire given to the mothers at 12+0-13+6 weeks+days of gestation; 
and child’s age at follow-up (years) which was reported in conjunction with filling in the 
ASQ.  
Statistical analyses 
We used multinomial logistic regression to test if children of overweight and obese women in 
comparison to children of normal weight women had higher odds for displaying mild 
developmental delay or failed to meet the development that is typical for the child’s age on 
any of the ASQ domains. We used continuation-ratio ordinal logistic regression when the 
developmental delay severity/pervasiveness sum-score was the outcome.  We repeated these 
analyses by replacing maternal overweight/obesity by maternal gestational hypertension, pre-
eclampsia and pre-pregnancy/chronic hypertension using women without these disorders as 
the comparison group; and maternal gestational and type 1 diabetes using women without 
these disorders as the comparison group. Unstandardized regression coefficients represent 
odds ratios (OR), and 95% Confidence Intervals (95% CI). In addition to the unadjusted 
effects, we report these associations as adjusted for the covariates and confounders.  
To test if any potential effects on child’s developmental milestones were specific to maternal 
overweight, obesity, or related hypertensive and diabetic pregnancy and pre-pregnancy 
disorders, we conducted two additional analyses. First, we made adjustments for the mutual 
effects of these conditions. We then tested the effects of these conditions by excluding women 
with the other conditions from the analyses, e.g. when we tested the effects of 
overweight/obesity we excluded women with hypertensive and diabetic pregnancy and pre-
pregnancy disorders from the analyses; Because overweight/obesity and the disorders were 
highly co-morbid in our sample (Supplemental Table 1) and because we used the ASQ -2SD 
and -1SD cutoffs to identify  developmental delay, our sample size permitted us to conduct 
the latter ‘restricted’ analyses only when we used the child’s developmental delay 
severity/pervasiveness sum-score as the outcome.  
 
Finally, we tested if exposure to any combination of overweight/obesity, and comorbid 
disorders (sum-score categorized into no disorder, one, two or more disorders) added to the 
neurodevelopmental adversity in the offspring. An effect was considered additive if the 
increment in the odds of displaying more severe and pervasive developmental delay was 
significantly higher for children of mothers with two or more than just one disorder.   
 
All statistical analyses were performed using SAS 9.4 (SAS Institute, Inc., Cary, NC, USA). 
 
Results 
 
Characteristics of the sample according to maternal early pregnancy normal weight, 
overweight and obesity are presented in Table 1. Supplemental Table 1 shows the prevalence 
of hypertensive and diabetic pregnancy and pre-pregnancy disorders according to maternal 
early pregnancy weight categories. Prevalence ratio of any one hypertensive or diabetic 
pregnancy and pre-pregnancy disorder was 2.05 and 3.86 times higher in the overweight and 
obese groups as compared to the normal weight group respectively, and of any two 
hypertensive and diabetic pregnancy and pre-pregnancy disorders 5.75 and 16.86 times higher 
in the overweight and obese groups as compared to the normal weight group, respectively.  
Overweight and obesity partook in over 93% cases of co-morbidities (Table 1).  
Table 2 shows the numbers of children who displayed mild developmental delay (-2SD > -≤ 
SD) and failed to meet the development that is typical for the child’s age (≤-2SD) according 
to maternal early pregnancy BMI and hypertensive and diabetic pregnancy and pre-pregnancy 
disorders groups. The number of children in the delay categories in women with type 1 
diabetes was too small for any analyses, therefore we do not present findings on type 1 
diabetes.   
Associations between maternal early pregnancy overweight and obesity and child’s 
developmental milestones 
Table 3 shows that in the unadjusted models children of overweight mothers had higher odds 
of displaying mild developmental delay on communication and fine motor skills and of failing 
to meet the development on the communication skills that is typical for the child’s age. These 
associations remained significant when we adjusted for covariates and confounders, and for 
comorbid disorders (Table 3). 
Children of  obese mothers had higher odds of displaying mild developmental delay on fine 
motor skills and of failing to meet the development on communication, fine motor, gross 
motor, problem solving and personal-social skills that is typical for the child’s age (Table 3). 
All the associations remained significant after adjustments for covariates and confounders and 
for comorbid disorders, except for two: the association with the mild delay in fine motor skills 
was rendered non-significant when adjusted for covariates and confounders and the 
association with failure to meet the development on problem solving skills that is typical for 
the child’s age was rendered non-significant when adjusted for comorbid disorders (Table 3). 
Table 4 shows that after all covariate and confounder adjustments and in models adjusted for 
comorbid disorders, children of overweight and obese mothers had higher odds of displaying 
more severe and pervasive developmental delay across the five ASQ domains. These effects 
did not change either when we excluded women with comorbid disorders from the analyses 
(Table 4 ‘restricted model’).  
 
Associations between maternal hypertensive and diabetic pregnancy and pre-pregnancy 
disorders and child’s developmental milestones 
Table 3 shows that children of mothers with pre-eclampsia had higher odds of mild 
developmental delay on communication skills and of failing to meet the development on 
communication and gross motor skills that is typical for the child’s age (Table 3). The latter 
association with the communication skills was rendered non-significant when adjusted for 
maternal overweight/obesity and diabetic pregnancy and pre-pregnancy disorders (Table 3).   
 
In the unadjusted and all adjustment models, children of mothers with gestational diabetes had 
higher odds of mild developmental delay on personal social skills and of failing to meet the 
development on communication skills that would be typical for the child’s age (Table 3). 
Maternal gestational diabetes was also associated with higher odds of failing to meet the 
development on gross motor and problems solving skills that would be typical for child’s age, 
but these associations were rendered non-significant when adjusted for maternal 
overweight/obesity and hypertensive pregnancy and pre-pregnancy disorders (Table 3).  
 
Table 4 shows that children of mothers with pre-eclampsia and gestational diabetes had 
higher odds of displaying more severe and pervasive developmental delay across the five 
ASQ domains (Table 4). The association of pre-eclampsia remained significant across all 
adjustment models and in the ‘restricted model’ with women with overweight/obesity and  
diabetic disorders excluded, but association of gestational diabetes was rendered non-
significant in the ‘restricted model’ (Table 4). 
 
Finally, we tested if the effects of maternal early pregnancy overweight/obesity and 
hypertensive and diabetic pregnancy and pre-pregnancy disorders were additive. While 
children of mothers with one (OR=1.32, 95% CI 1.1,1.60, p=0.004) and two or more of these 
conditions (OR=1.52, 95% CI 1.18,1.98 p=0.001) had an increased odds for displaying more 
severe and pervasive developmental delay, the increment in the odds between one and two or 
more conditions was not statistically significant (p-value=0.19). 
 
Discussion  
 
In this prospective pregnancy cohort study, maternal early pregnancy obesity was associated 
with delay in developmental milestones in her offspring aged 23-69 months. Children of 
obese women had 1.81-2.74 higher odds of failing to meet the development in 
communication, fine and gross motor, problems solving and personal-social skills that is 
typical for the child’s age. When tested across all of these five domains, the delay these 
children displayed was more severe and pervasive. Maternal early pregnancy overweight was 
also associated with delay in developmental milestones, but this delay was evident on a 
narrower spectrum of skills, namely on communication and fine motor skills, and the delay in 
communication skills was mild. Yet, maternal early pregnancy overweight also predicted a 
more severe and pervasive developmental delay of the child across the five ASQ domains. 
These associations changed only a little when we adjusted for covariates and confounders and 
comorbid disorders. Exclusion of women with the comorbid disorders in the restricted 
analyses allowed us to entirely eliminate potential confounding/effect modification by the 
comorbid disorders, and for the first time to demonstrate the independent effects of 
overweight and obesity on the severity and pervasiveness of the child’s developmental delay 
across the different developmental domains. 
  
Our study also revealed that maternal pre-eclampsia was associated with developmental 
delays in communication and gross motor skills and gestational diabetes with delays in 
communication, gross motor, problem solving and personal social skills. Both pre-eclampsia 
and gestational diabetes were associated with the score indicating more severe and pervasive 
developmental delay across the five ASQ domains. While these associations were not 
explained by the covariates and confounders, the restricted analyses revealed that only the 
associations between pre-eclampsia and the severity/pervasiveness score of developmental 
delay remained significant when women with overweight/obesity and diabetic pregnancy and 
pre-pregnancy disorders were excluded from the analyses.  
 
These findings combined with the finding that there were no additive effects of maternal early 
pregnancy overweight/obesity and comorbid disorders on child neurodevelopmental adversity 
suggest that maternal overweight, obesity and pre-eclampsia may carry harmful effects on 
developmental delay of the child that are not, contrary to what we expected, explained by the 
comorbid disorders. Gestational diabetes carries similar harmful effects, but these are at least 
partially explained by maternal overweight/obesity and the other disorders. As the prevalence 
rates of maternal overweight and obesity and comorbid disorders are increasing, our findings 
carry an important public health message: prevention and effective management of maternal 
overweight/obesity and comorbid conditions should not only improve the quality of life and 
wellbeing of the pregnant mothers themselves, but decrease the burden of 
neurodevelopmental adversities in the next generation. 
 
A major strength of the study relates to the study design: a fifth of our sample was recruited 
based on their known risk factor status for pre-eclampsia and IUGR. This resulted in an 
enrichment of the pregnancy and pre-pregnancy disorders in our sample, amplifying the 
statistical power to study their independent effects. Of note, when this study was performed, 
guidelines for gestational diabetes screening in Finland were changed from risk-based to 
comprehensive screening. Thus, our study is likely to include milder cases of gestational 
diabetes than previous studies(30). Inclusion of milder cases of GDM may have resulted in 
finding associations with milder developmental delays in some skills, which is in line with 
our findings on overweight, suggesting dose-response associations. However, in interpretation 
the small number of children failing to meet the age-appropriate skills should be taken into 
account. The other strengths include a prospective study design, data of exposures derived 
from the MBR and medical records, and unlike in a majority of the previous studies 
measurements of weight and height conducted in the first antenatal clinic visit in early 
pregnancy, and a large and homogenous study sample. Even though the developmental 
milestones data were mother-reported, which may introduce a bias, and ASQ is a screening 
tool rather than a diagnostic instrument, the ASQ has been shown to be reliable, it is well-
validated, and demonstrates high sensitivity and specificity to screen children requiring 
further developmental assessment, monitoring or special education(26-28).  
 
However, the underlying mechanisms still remain unknown. Experimental work in rodents 
suggests that the mechanisms that link maternal obesity with cognitive dysfunction in the 
offspring may include alterations in insulin, glucose and leptin regulation, inflammation, and 
decreased expression of brain-derived neurothropic factor, particularly in the hippocampus and 
cortex(31, 32). A recent study showed that hyperglycemia in the pregnant rat can retard 
dendritic development in the fetal brain and that these changes are a result from abnormal 
insulin/IGF-I signaling in the fetal brain(33). It is also possible that insulin resistance, 
characterizing human neonates from obese pregnancies(34, 35), impedes neuronal growth in 
the fetal brain. Obesity is also associated with changes in the maternal microbiota(36); and these 
microbial changes are transferred from mothers to infants during delivery and 
breastfeeding(37), with caesarian section/vaginal delivery, and breastfeeding/not breastfeeding 
influencing infant’s microbiota differently(38). Of note is that obese mothers have 
disproportionally high rates of caesarian section deliveries(39).  There is also evidence that 
maternal obesity is associated with delayed lactogenesis and reduced rates of breastfeeding(40). 
Other mechanisms may relate to lifestyle behaviors, including unhealthier diet, and concomitant 
alterations in micro- and macronutrients, smoking, alcohol use and physical inactivity during 
pregnancy, and maternal socio-economic position. In our study the associations were 
independent of maternal smoking and alcohol use during pregnancy and maternal education, 
however. Clearly further studies unraveling the underlying mechanisms are warranted. 
 
Another major study limitation is the follow-up sample attrition, which was not independent 
of maternal characteristics. The mothers of children who participated in this study were older, 
more often primiparous, and had on average higher educational attainment as compared to 
those who were eligible, but did not participate. This would be expected to cause bias only if 
the associations between maternal metabolic conditions and child development differ between 
participants and non-participants. Further, even though our study design resulted in a large 
number of overweight/obese women and women with hypertensive and diabetic pregnancy 
and pre-pregnancy disorders, the number of women with type 1 diabetes was small and 
precluded studying its effect entirely. In addition, although we were able to control for a 
number of potential covariates, we cannot entirely exclude the possibility of residual 
confounding. However, since the associations were consistently significant in largely all of 
the studied analytic models, we do not anticipate residual confounding to be a source of false-
positive associations.  
 
Conclusion 
 
In all, our study findings show that maternal early pregnancy overweight, obesity, and pre-
eclampsia are associated, independently of each other and the other comorbid disorders, with 
neurodevelopmental harm for the developing offspring. Gestational diabetes also carried 
neurodevelopmental harm, which was partially explained by maternal overweight/obesity and 
hypertensive disorders. Our findings suggest that efforts to optimize weight management and 
to reduce the incidence of modifiable pregnancy and pre-pregnancy disorders are likely to 
result in neurodevelopmental benefits in the offspring.  
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Table 1. Characteristics of the study population according to maternal early pregnancy normal weight, overweight and obesity 
Normal weight 
n=1741 
Overweight 
n=456 
Obese    
n=307 P-values between 
groups N (%) or M (SD) N (%) or M (SD) N (%) or M (SD) 
Maternal characteristics : 
Age at delivery (years) 31.5 (4.5) 32.2 (4.7) 32.6 (5.1) <0.0001 
    Data not available, n (%) 0 0 0 
Education <0.0001 
    Lower secondary or less 583 (33.5%) 200 (43.9%) 158 (51.5%) 
    Upper secondary 449 (25.8%) 131 (28.7%) 82 (26.7%) 
    Tertiary 706 (40.6%) 125 (27.4%) 67 (21.8%) 
    Data not available, n (%) 3 (0%) 0 0 
Parity 0.73 
    Primiparous 736 (42.3%) 183 (40.3%) 130 (42.3%) 
    Multiparous 1002 (57.7%) 271 (59.7%) 177 (57.7%) 
    Data not available, n (%) 3 (0%) 2 (0%) 0 
Smoking during pregnancy 0.09 
   No 1637 (94.2%) 416 (91.2%) 287 (93.5%) 
   Quit during first trimester 50 (2.9%) 24 (5.2%) 8 (2.6%) 
   Smoked throughout pregnancy 51 (2.9%) 16 (3.5%) 12 (3.9%) 
   Data not available, n (%) 3 (0%) 0 0 
Alcohol use during pregnancy 0.19 
   No 1301 (74.7%) 341 (74.8%) 249 (81.1%) 
   Yes 273 (15.7%) 70 (15.4%) 34 (11.1%) 
   Data not available, n (%) 167 (9.6%) 45 (9.9%) 24 (7.8%) 
Delivery mode <0.0001 
   Vaginal 1490 (85.7%) 364 (79.8%) 215 (70.0%) 
   Caesarean  241 (13.8%) 88 (19.3%) 90 (29.3%) 
   Data not available, n (%) 10 (0.5%) 4 (0.9%) 2 (0.7%) 
Hypertensive pregnancy and pre-
pregnancy disorders 
<0.0001 
    Normotension 1604 (92.1%) 390 (85.5%) 222 (72.3%) 
    Gestational hypertension  53 (3.0%) 19 (4.2%) 23 (7.5%) 
    Pre-eclampsia  52 (3.0%) 27 (5.9%) 27 (8.8%) 
    Pre-pregnancy / Chronic 32 (1.8%) 20 (4.4%) 35 (11.4%) 
    hypertension  
    Data not available, n (%) 0 0 0 
Diabetic pregnancy and pre-pregnancy 
disorders 
<0.0001 
    No diabetes 1652 (94.9%) 383 (84.0%) 212 (69.1%) 
    Gestational diabetes   85 (4.9%) 69 (15.1%) 94 (30.6%) 
 Type 1 diabetes 4 (0.2%) 4 (0.9%) 1 (0.3%) 
    Data not available, n (%) 0 0 0 
Number of  hypertensive or diabetic    
pregnancy and pre-pregnancy disorders 
<0.0001 
 No disorders 1529 (87.8%) 335 (73.5%) 155 (50.5%) 
 Any one disorder 198 (11.4%) 103 (24.2%) 124 (29.2%) 
 Any two disorders  14 (0.8%) 18 (4.0%) 28 (9.1%) 
    Data not available, n (%) 0 0 0 
Child characteristics: 
Sex 0.34 
   Girls 866 (49.7%) 231 (50.7%) 140 (45.6%) 
   Boys 875 (50.3%) 225 (49.3%) 167 (54.4%) 
   Data not available, n (%) 0 0 0 
Gestational age, weeks 39.9 (1.5) 39.9 (1.5) 40.0 (1.6) 0.58 
   Data not available, n (%) 0 0 0 
Birth weight, grams 3498 (503.7) 3549.8 (506.4) 3659 (517.2) <0.0001 
   Data not available, n (%) 0 0 0 
Birth length, centimetres  50.1 (2.2) 50.2 (2.4) 50.7 (2.3) 0.0001 
   Data not available, n (%) 0 0 0 
Age at follow-up, months 41.8 (8.2) 42.3 (8.2) 43.6 (8.4) 0.002 
   Data not available, n (%) 0 0 0 
Table 2. Number of cases and prevalence of mild developmental delay and failure to achieve developmental milestones in children according 
to maternal weight category, hypertensive and diabetic disorders status  
Maternal pre-pregnancy and pregnancy conditions Mild developmental delay 
N (%) 
Failure to achieve 
developmental milestone 
N (%) 
Normal weight 
Communication skills 82 (4.7%) 51 (2.9%) 
Fine motor skills 126 (7.2%) 73 (4.2%) 
Gross motor skills 125 (7.2%) 79 (4.5%) 
Problem solving skills 115 (6.6%) 71 (4.1%) 
Personal social skills 157 (9.0%) 59 (3.4%) 
Any domain 332 (19.1%) 235 (13.5%) 
Overweight 
Communication skills 34 (7.5%) 27 (5.9%) 
Fine motor skills 56 (12.3%) 20 (4.4%) 
Gross motor skills 34 (7.5%) 30 (6.6%) 
Problem solving skills 30 (6.6%) 28 (6.1%) 
Personal social skills 50 (11.0%) 20 (4.4%) 
Any domain 100 (21.9%) 78 (17.1%) 
Obesity 
Communication skills 17 (5.5%) 23 (7.5%) 
Fine motor skills 32 (10.4%) 29 (9.4%) 
Gross motor skills 22 (7.2%) 26 (8.5%) 
Problem solving skills 21 (6.8%) 22 (7.2%) 
Personal social skills 27 (8.8%) 19 (6.2%) 
Any domain 56 (18.2%) 67 (21.8%) 
Normotension 
Communication skills 113 (5.1%) 83 (3.8%) 
Fine motor skills 185 (8.4%) 106 (4.8%) 
Gross motor skills 162 (7.3%) 113 (5.1%) 
Problem solving skills 152 (6.9%) 99 (8.4%) 
Personal social skills 204 (9.2%) 84 (3.8%) 
Any domain 429 (19.4%) 328 (14.8%) 
Gestational Hypertension 
Communication skills 2 (2.1%) 5 (5.3%) 
Fine motor skills 10 (10.5%) 8 (8.4%) 
Gross motor skills 5 (5.3%) 4 (4.2%) 
Problem solving skills 3 (3.2%) 8 (8.4%) 
Personal social skills 8 (8.4%) 4 (4.2%) 
Any domain 15 (15.8%) 15 (15.8%) 
 Preeclampsia 
Communication skills 11 (8.3%) 8 (7.9%) 
Fine motor skills 12 (11.3%) 3 (2.8%) 
Gross motor skills 11 (10.4%) 12 (11.3%) 
Problem solving skills 4 (3.8%) 9 (8.5%) 
Personal social skills 15 (14.2%) 4 (3.8%) 
Any domain 30 (28.3%) 22 (5.8%) 
 Pre-pregnancy / Chronic Hypertension 
Communication skills 7 (8.1%) 5 (5.8%) 
Fine motor skills 7 (8.1%) 5 (5.8%) 
Gross motor skills 3 (3.5%) 6 (6.9%) 
Problem solving skills 7 (8.1%) 5 (5.8%) 
Personal social skills 7 (8.1%) 6 (6.9%) 
Any domain 14 (2.9%) 15 (4.0%) 
No diabetes 
Communication skills 116 (5.2%) 77 (3.4%) 
Fine motor skills 190 (8.5%) 105 (4.7%) 
Gross motor skills 164 (7.3%) 114 (5.1%) 
Problem solving skills 145 (6.5%) 102 (4.5%) 
Personal social skills 199 (8.9%) 87 (3.9%) 
Any domain 430 (19.4%) 331 (14.7%) 
Gestational diabetes 
Communication skills 16 (6.5%) 23 (9.3%) 
Fine motor skills 21 (8.5%) 17 (6.9%) 
Gross motor skills 15 (6.1%) 21 (8.5%) 
Problem solving skills 21 (8.5%) 19 (7.7%) 
Personal social skills 34 (13.7%) 11 (4.4%) 
Any domain 54 (21.8%) 48 (19.4%) 
Type 1 diabetes 
Communication skills 1 (11.1%) 1 (11.1%) 
Fine motor skills 3 (33.3%) 0 
Gross motor skills 2 (22.2%) 0 
Problem solving skills 0 0 
Personal social skills 1 (11.1%) 0 
Any domain 4 (44.4%) 1 (11.1%) 
Table 3. Associations between maternal pregnancy and pre-pregnancy disorders and mild developmental delay/developmental delay defined as 1 SD/2 SD from the age specific mean ASQ 
score 
 Unadjusted model Adjusted model* Adjusted model** 
Pregnancy and pre-pregnancy disorders Odds Ratio (95% 
Confidence Interval) 
P-value Odds Ratio (95% 
Confidence Interval) 
P-value Odds Ratio (95% 
Confidence Interval) 
P-value 
Overweight       
Communication skills, mild developmental delay   1.67 (1.11 to 2.53) 0.001 1.59 (1.03 to 2.41) 0.04 1.59 (1.04 to 2.43) 0.03 
Fine motor skills,  mild developmental delay   1.77 (1.27 to 2.47) 0.0008 1.81 (1.27 to 2.56) 0.001 1.77 (1.26 to 2.49) 0.0009 
Gross motor skills, mild developmental delay 1.06 (0.71 to 1.57) 0.78 1.04 (0.70 to 1.56) 0.85 1.07 (0.72 to 1.60) 0.74 
Problem solving skills,  mild developmental delay 1.0 (0.66 to 1.52) 1.0 0.94 (0.61 to 1.45) 0.78 0.99 (0.65 to 1.51) 0.95 
Personal social skills,  mild developmental delay 1.26 (0.90 to 1.77) 0.18 1.27 (0.89 to 1.80) 0.18 1.17 (0.83 to 1.65) 0.37 
       
Communication skills, failure to meet developmental milestone   2.14 (1.32 to 3.45) 0.002 2.10 (1.28 to 3.43) 0.003 1.88 (1.15 to 3.07) 0.01 
Fine motor skills,   failure to meet developmental milestone   1.09 (0.66 to 1.81) 0.73 1.18 (0.70 to 1.99) 0.53 1.10 (0.66 to 1.84) 0.72 
Gross motor skills,  failure to meet developmental milestone   1.48 (0.96 to 2.28) 0.08 1.42 (0.91 to 2.23) 0.13 1.39 (0.89 to 2.16) 0.15 
Problem solving skills,   failure to meet developmental milestone   1.51 (0.96 to 2.37) 0.07 1.53 (0.96 to 2.45) 0.07 1.41 (0.89 to 2.23) 0.14 
Personal social skills,   failure to meet developmental milestone   1.34 (0.80 to 2.26) 0.27 1.39 (0.81 to 2.38) 0.23 1.35 (0.80 to 2.27) 0.27 
       
 Obesity       
Communication skills, mild developmental delay   1.26 (0.74 to 2.16) 0.40 1.07 (0.61 to 1.87) 0.81 1.12 (0.63 to 2.0) 0.69 
Fine motor skills,  mild developmental delay   1.59 (1.06 to 2.40) 0.03 1.49 (0.96 to 2.31) 0.08 1.66 (1.08 to 2.57) 0.02 
Gross motor skills, mild developmental delay 1.04 (0.65 to 1.67) 0.87 0.91 (0.56 to 1.49) 0.71 1.13 (0.69 to 1.86) 0.63 
Problem solving skills,  mild developmental delay 1.07 (0.66 to 1.73) 0.79 1.03 (0.62 to 1.70) 0.92 1.01 (0.60 to 1.70) 0.97 
Personal social skills,  mild developmental delay 1.01 (0.66 to 1.55) 0.96 0.95 (0.61 to 1.50) 0.83 0.85 (0.54 to 1.35) 0.50 
       
Communication skills, failure to meet developmental milestone   2.74 (1.65 to 2.56) 0.0001 2.62 (1.53 to 4.50) 0.0005 2.06 (1.18 to 3.60) 0.01 
Fine motor skills,   failure to meet developmental milestone   2.49 (1.59 to 3.91) <0.0001 2.59 (1.59 to 4.22) <0.0001 2.47 (1.52 to 4.02) 0.0003 
Gross motor skills,  failure to meet developmental milestone   1.94 (1.22 to 3.08) 0.005 1.94 (1.19 to 3.17) 0.007 1.67 (1.02 to 2.79) 0.04 
Problem solving skills,   failure to meet developmental milestone  1.81 (1.10 to 2.98) 0.02 1.87 (1.11 to 3.17) 0.02 1.51 (0.88 to 2.58) 0.13 
Personal social skills,   failure to meet developmental milestone   1.89 (1.11 to 3.23) 0.02 1.86 (1.05 to 3.30) 0.03 1.83 (1.03 to 3.26) 0.04 
Gestational Hypertension 
Communication skills, mild developmental delay   0.40 (0.10 to 1.66) 0.21 0.40 (0.10 to 1.67) 0.21 0.38 (0.09 to 1.58) 0.18 
Fine motor skills,  mild developmental delay   1.35 (0.68 to 2.65) 0.39 1.38 (0.68 to 2.79) 0.37 1.22 (0.61 to 2.42) 0.57 
Gross motor skills, mild developmental delay 0.71 (0.28 to 1.76) 0.46 0.68 (0.27 to 1.72) 0.42 0.69 (0.27 to 1.72) 0.42 
Problem solving skills,  mild developmental delay 0.46 (0.15 to 1.49) 0.20 0.47 (0.15 to 1.51) 0.20 0.46 (0.14 to 1.47) 0.19 
Personal social skills,  mild developmental delay 0.92 (0.44 to 1.92) 0.82 0.88 (0.41 to 1.87) 0.73 0.89 (0.42 to 1.88) 0.76 
Communication skills, failure to meet developmental milestone   1.37 (0.54 to 3.46) 0.51 1.45 (0.56 to 3.74) 0.44 1.11 (0.43 to 2.85) 0.82 
Fine motor skills,   failure to meet developmental milestone   1.88 (0.88 to 4.0) 0.10 1.76 (0.80 to 3.88) 0.16 1.60 (0.75 to 3.45) 0.22 
Gross motor skills,  failure to meet developmental milestone   0.81 (0.29 to 2.24) 0.68 0.75 (0.27 to 2.11) 0.59 0.75 (0.26 to 2.02) 0.54 
Problem solving skills,   failure to meet developmental milestone  1.90 (0.89 to 4.03) 0.10 1.82 (0.84 to 3.94) 0.13 1.74 (0.81 to 3.73) 0.15 
Personal social skills,   failure to meet developmental milestone   1.11 (0.40 to 3.11) 0.84 1.09 (0.38 to 3.13) 0.87 1.02 (0.36 to 2.89) 0.98 
Preeclampsia 
Communication skills, mild developmental delay   2.32 (1.20 to 4.47) 0.01 2.48 (1.25 to 4.95) 0.01 2.15 (1.10 to 4.19) 0.02 
Fine motor skills,  mild developmental delay   1.40 (0.75 to 2.60) 0.29 1.45 (0.75 to 2.81) 0.28 1.18 (0.63 to 2.23) 0.61 
Gross motor skills, mild developmental delay 1.59 (0.83 to 3.04) 0.16 1.53 (0.78 to 3.0) 0.22 1.49 (0.77 to 2.89) 0.24 
Problem solving skills,  mild developmental delay 0.56 (0.20 to 1.54) 0.26 0.59 (0.21 to 1.65) 0.31 0.56 (0.20 to 1.56) 0.27 
Personal social skills,  mild developmental delay 1.62 (0.92 to 2.86) 0.09 1.58 (0.87 to 2.88) 0.13 1.59 (0.89 to 2.82) 0.12 
Communication skills, failure to meet developmental milestone   2.30 (1.08 to 4.90) 0.03 2.47 (1.10 to 5.59) 0.03 1.81 (0.83 to 3.93) 0.13 
Fine motor skills,   failure to meet developmental milestone   0.61 (0.19 to 1.96) 0.40 0.51 (0.15 to 1.69) 0.27 0.52 (0.16 to 1.68) 0.27 
Gross motor skills,  failure to meet developmental milestone   2.49 (1.32 to 4.69) 0.005 1.82 (0.91 to 3.62) 0.09 2.23 (1.17 to 4.26) 0.01 
Problem solving skills,   failure to meet developmental milestone  1.92 (0.94 to 3.93) 0.07 1.74 (0.81 to 3.71) 0.15 1.75 (0.85 to 3.62) 0.13 
Personal social skills,   failure to meet developmental milestone   1.05 (0.38 to 2.93) 0.94 1.09 (0.38 to 3.18) 0.87 0.95 (0.34 to 2.67) 0.92 
       
Pre-pregnancy/Chronic hypertension       
Communication skills, mild developmental delay   1.65 (0.74 to 3.67) 0.22 1.71 (0.74 to 3.91) 0.21 1.49 (0.66 to 3.39) 0.33 
Fine motor skills,  mild developmental delay   0.97 (0.44 to 2.13) 0.93 0.97 (0.42 to 2.22) 0.94 0.81 (0.36 to 1.82) 0.61 
Gross motor skills, mild developmental delay 0.46 (0.14 to 1.46) 0.19 0.43 (0.13 to 1.41) 0.16 0.44 (0.14 to 1.43) 0.17 
Problem solving skills,  mild developmental delay 1.23 (0.56 to 2.72) 0.61 1.18 (0.52 to 2.68) 0.69 1.16 (0.51 to 2.61) 0.72 
Personal social skills,  mild developmental delay 0.93 (0.42 to 2.04) 0.85 0.86 (0.38 to 1.96) 0.73 0.86 (0.38 to 1.91) 0.71 
       
Communication skills, failure to meet developmental milestone   2.61 (0.63 to 4.09) 0.32 1.95 (0.74 to 5.12) 0.18 1.02 (0.39 to 2.67) 0.97 
Fine motor skills,   failure to meet developmental milestone   1.21 (0.48 to 3.05) 0.69 1.18 (0.45 to 3.10) 0.74 0.85 (0.33 to 2.22) 0.75 
Gross motor skills,  failure to meet developmental milestone   1.31 (0.56 to 3.06) 0.54 1.22 (0.51 to 2.95) 0.66 1.02 (0.43 to 2.44) 0.97 
Problem solving skills,   failure to meet developmental milestone   1.35 (0.53 to 3.42) 0.53 1.36 (0.52 to 3.55) 0.53 1.09 (0.42 to 2.82) 0.86 
Personal social skills,   failure to meet developmental milestone   1.93 (0.81 to 4.57) 0.13 2.24 (0.93 to 5.91) 0.07 1.61 (0.66 to 3.92) 0.29 
       
Gestational diabetes       
Communication skills, mild developmental delay   1.34 (0.78 to 2.30) 0.29 1.22 (0.70 to 2.12) 0.49 1.19 (0.67 to 2.11) 0.55 
Fine motor skills,  mild developmental delay   1.01 (0.63 to 1.63) 0.96 0.93 (0.57 to 1.51) 0.76 0.83 (0.51 to 1.36) 0.46 
Gross motor skills, mild developmental delay 0.85 (0.49 to 1.47) 0.56 0.85 (0.49 to 1.49) 0.57 0.85 (0.48 to 1.51) 0.58 
Problem solving skills,  mild developmental delay 1.38 (0.85 to 2.23) 0.19 1.31 (0.80 to 2.15) 0.28 1.40 (0.84 to 2.32) 0.20 
Personal social skills,  mild developmental delay 1.65 (1.11 to 2.43) 0.01 1.53 (1.01 to 2.31) 0.04 1.69 (1.12 to 2.56) 0.01 
       
Communication skills, failure to meet developmental milestone   2.90 (1.78 to 4.72) <0.0001 2.90 (1.74 to 4.72) <0.0001 2.17 (1.28 to 3.66) 0.003 
Fine motor skills,   failure to meet developmental milestone   1.48 (0.87 to 2.53) 0.15 1.46 (0.84 to 2.56) 0.18 1.11 (0.63 to 1.95) 0.73 
Gross motor skills,  failure to meet developmental milestone   1.71 (1.05 to 2.78) 0.03 1.66 (1.0 to 2.76) 0.05 1.40 (0.83 to 2.35) 0.21 
Problem solving skills,   failure to meet developmental milestone   1.78 (1.07 to 2.96) 0.03 1.80 (1.06 to 3.05) 0.03 1.47 (0.85 to 2.53) 0.17 
Personal social skills,   failure to meet developmental milestone   1.22 (0.64 to 2.32) 0.54 1.18 (0.61 to 2.31) 0.62 0.94 (0.47 to 1.85) 0.85 
       
   Pre-pregnancy Type 1 diabetes 
Communication skills, mild developmental delay   2.50 (0.31 to 20.50) 0.39 2.43 (0.27 to 21.96) 0.43 1.78 (0.21 to 15.01) 0.60 
Fine motor skills,  mild developmental delay   5.04 (1.25 to 20.31) 0.02 3.94 (0.87 to 17.88) 0.07 4.14 (1.0 to 17.13) 0.05 
Gross motor skills, mild developmental delay 3.39 (0.70 to 16.45) 0.13 3.02 (0.57 to 16.17) 0.20 3.18 (0.63 to 15.97) 0.16 
Problem solving skills,  mild developmental delay *** *** *** 
Personal social skills,  mild developmental delay 1.22 (0.15 to 9.83) 0.85 1.30 (0.15 to 11.14) 0.81 1.04 (0.13 to 8.48) 0.95 
Communication skills, failure to meet developmental milestone   3.77 (0.46 to 31.0) 0.22 2.40 (0.25 to 23.13) 0.45 2.69 (0.32 to 22.64) 0.36 
Fine motor skills,   failure to meet developmental milestone   *** *** *** 
Gross motor skills,  failure to meet developmental milestone   *** *** *** 
Problem solving skills,   failure to meet developmental milestone  *** *** *** 
Personal social skills,   failure to meet developmental milestone   *** *** *** 
*Adjusted for maternal age at delivery, mode of delivery, parity, maternal smoking and alcohol use during pregnancy, maternal education, child’s gestational age, birthweight, sex and age at follow-up.
** Adjusted for other pregnancy and pre-pregnancy disorders 
***Number of cases born to the mothers with type 1 diabetes is too small to calculate OR 
Table 4. Associations between maternal pregnancy and pre-pregnancy disorders and  any mild delay, any failure to achieve developmental milestone, and severity of developmental delay in their children defined as total 
number of SD below the mean for the five ASQ subscales  
 
Pregnancy and pre-pregnancy disorders  
Unadjusted model 
(N=2504) 
Adjusted model* 
(N=2482) 
Adjusted model** 
(N=2504) 
 Restricted models*** 
(NBMI=2019, NHD=1652, NDIABETES=1604) 
OR 
(95% Confidence Interval) 
 
P-value 
OR 
(95% Confidence Interval) 
 
P-value 
OR 
(95% Confidence Interval) 
 
P-value 
OR 
(95% Confidence Interval) 
 
P-value 
Number 
of cases 
Overweight          
Any mild delay 1.27 (0.98 to 1.65) 0.07 1.22 (0.94 to 1.60) 0.14 1.22 (0.94 to 1.59) 0.13 1.27 (0.94 to 1.71) 0.12 72 
Any failure to achieve developmental milestone 1.40 (1.05 to1.87) 0.02 1.40 (1.04 to1.90) 0.03 1.36 (1.02 to1.82) 0.04 1.33 (0.95 to1.86) 0.10 54 
Severity/pervasiveness of developmental delay 1.38 (1.12 to 1.70) 0.002 1.38 (1.11 to 1.72) 0.003 1.34 (1.09 to 1.66) 0.006 1.32 (1.04 to 1.68) 0.02 335 
Obesity          
Any mild delay 1.08 (0.78 to 1.49) 0.66 0.98 (0.70 to 1.37) 0.89 1.01 (0.72 to 1.43) 0.94 1.11 (0.71 to 1.73) 0.65 28 
Any failure to achieve developmental milestone 1.82 (1.33 to 2.49) 0.0002 1.80 (1.28 to 2.52) 0.0007 1.70 (1.22 to 2.38) 0.002 1.87 (1.23 to 2.86) 0.003 34 
Severity/pervasiveness of developmental delay 1.51 (1.18 to 1.94) 0.001 1.48 (1.14 to 1.92) 0.003 1.43 (1.10 to 1.86) 0.008 1.58 (1.13 to 2.20) 0.007 155 
Gestational Hypertension          
Any mild delay 0.79 (0.44 to 1.39) 0.41 0.76 (0.42 to 1.36) 0.35 0.76 (0.43 to 1.34) 0.34 0.74 (0.32 to 1.68) 0.47 7 
Any failure to achieve developmental milestone 1.03 (0.58 to 1.82) 0.93 0.96 (0.53 to 1.74) 0.88 0.93 (0.52 to 1.65) 0.80 0.88 (0.37 to 2.12) 0.78 6 
Severity/pervasiveness of developmental delay 0.88 (0.56 to 1.38) 0.58 0.85 (0.53 to 1.34) 0.48 0.82 (0.53 to 1.29) 0.40 0.67 (0.34 to 1.32) 0.24 48 
 Preeclampsia          
Any mild delay 1.89 (1.19 to 2.99) 0.007 1.91 (1.18 to 3.07) 0.008 1.78 (1.11 to 2.83) 0.02 2.35 (1.19 to 4.64) 0.01 14 
Any failure to achieve developmental milestone 1.81 (1.09 to 3.02) 0.02 1.59 (0.92 to 2.74) 0.09 1.61 (0.96 to 2.69) 0.07 2.80 (1.37 to 5.75) 0.005 12 
Severity/pervasiveness of developmental delay 1.65 (1.14 to 2.40) 0.008 1.55 (1.04 to 2.30) 0.03 1.52 (1.04 to 2.23) 0.03 2.19 (1.30 to 3.70) 0.003 48 
 Pre-pregnancy / Chronic Hypertension         
Any mild delay 0.82 (0.45 to 1.49) 0.51 0.75 (0.41 to 1.39) 0.37 0.76 (0.41 to 1.39) 0.37 0.78 (0.26 to 2.30) 0.64 4 
Any failure to achieve developmental milestone 1.15 (0.64 to 2.01) 0.64 1.12 (0.61 to 2.05) 0.73 0.92 (0.51 to 1.67) 0.78 1.08 (0.36 to 3.21) 0.89 4 
Severity/pervasiveness of developmental delay 1.06 (0.67 to 1.67) 0.79 1.04 (0.65 to 1.67) 0.86 0.89 (0.93 to 1.62) 0.63 1.0 (0.44 to 2.30) 1.0 27 
Gestational diabetes          
Any mild delay 1.29 (0.92 to 1.78) 0.15 1.18 (0.83 to 1.67) 0.34 1.26 (0.89 to 1.79) 0.19 1.52 (0.88 to 2.64) 0.13 19 
Any failure to achieve developmental milestone 1.48 (1.04 to 2.09) 0.03 1.41 (0.98 to 2.03) 0.07 1.22 (0.85 to 1.76) 0.29 1.0 (0.48 to 2.08) 0.99 9 
Severity/pervasiveness of developmental delay 1.40 (1.08 to 1.81) 0.01 1.31 (1.0 to 1.72) 0.05 1.23 (0.94 to 1.62) 0.13 1.20 (0.74 to 1.91) 0.46 74 
Type 1 diabetes          
Any mild delay 3.46 (0.86 to 13.88) 0.08 4.14 (0.89 to 19.27) 0.07 2.90 (0.71 to 11.88) 0.14 ****  0 
Any failure to achieve developmental milestone 1.12 (0.13 to 10.07) 0.92 1.15 (0.11 to 11.77) 0.91 0.91 (0.10 to 8.27) 0.94 ****  0 
Severity/pervasiveness of developmental delay 1.85 (0.58 to 5.84) 0.30 1.77 (0.51 to 6.19) 0.37 1.51 (0.47 to 4.83) 0.49 ****  1 
*Adjusted for maternal age at delivery, mode of delivery, parity, maternal smoking and alcohol use during pregnancy, maternal education, child’s gestational age, birthweight, sex and age at follow-up.  
** Adjusted for other pregnancy and pre-pregnancy disorders 
****Women with other pregnancy disorders are excluded (i.e., analyses of pre-pregnancy body mass index excludes women with gestational hypertension, preeclampsia, pre-pregnancy/chronic hypertension, gestational diabetes and pre-
pregnancy type 1 diabetes; analyse of hypertensive disorder excludes women with pre-pregnancy overweight, obesity, and gestational diabetes and pre-pregnancy type 1 diabetes; analyses of diabetes excludes women with pre-pregnancy 
overweight, obesity and gestational hypertension, preeclampsia, and pre-pregnancy/chronic hypertension,)  
****Only one woman with type 1 diabetes was normal weight and normotensive.  
 
Table 5. Additive effects of maternal pregnancy and pre-pregnancy disorders on any mild developmental delay, failure to meet any developmental 
milestone, and severity of developmental milestones delay in the offspring 
Number of pregnancy and pre-pregnancy disorders  
Unadjusted model Adjusted model* 
OR         
(95% Confidence Interval) 
P-value OR         
(95% Confidence Interval) 
P-value 
Mild developmental delay in any of the developmental milestones 
No disorders 0.81 (0.65 to 1.02) 0.08 0.83 (0.65 to 1.05) 0.12 
One disorder Reference Reference 
Two and more disorders 1.10 (0.77 to 1.55) 0.61 1.02 (0.71 to 1.46) 0.93 
Failure to meet any developmental milestone 
No disorders 0.71 (0.55 to 0.91) 0.007 0.70 (0.54 to 0.92) 0.009 
One disorder Reference Reference 
Two and more disorders 1.26 (0.88 to 1.81) 0.21 1.17 (0.80 to 1.72) 0.41 
Severity of developmental delay 
No disorders 0.74 (0.62 to 0.90) 0.002 0.73 (0.60 to 0.88) 0.001 
One disorder Reference Reference 
Two and more disorders 1.20 (0.91 to 1.59) 0.19 1.10 (0.83 to 1.47) 0.51 
*Adjusted for maternal age at delivery, mode of delivery, parity, maternal smoking and alcohol use during pregnancy, maternal education, child’s gestational 
age, birthweight, sex and age at follow-up.   
**Calculated from the unadjusted model 
